Please select the option that best describes you:

In light of RIGHT Choice trial data, when will you opt for a CDK 4/6 inhibitor plus AI instead of chemotherapy in patients with metastatic HR-positive HER2-negative breast cancer with visceral crisis?  

RIGHT Choice trial presented at SABCS 2022



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at NYU Winthrop Hospital
RIGHT Choice: Less toxic
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Tripler Army Medical Center
Will defer chemo.
Sign in or Register to read more

Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at Pacific Cancer Care
Is this on trial? How do you get it approved with ...
Medical Oncologist at Fort Sutter Med Onc/Hem
The RIGHT Choice trial just presented at SABCS.
Sign in or Register to read more